Trana Discovery, a drug discovery technology company, helps its partners find novel classes of drugs for the treatment of serious viral, fungal, and bacterial infectious diseases. The technology identifies compounds that work through a unique mechanism of action: inhibition of the target pathogen’s ability to use transfer RNA (tRNA) essential for protein synthesis or replication.

The use of Trana Discovery technology can unlock the value – scientific, human, and financial – hidden in drug compound libraries, expedite the discovery of new drugs, and provide opportunities for exclusive rights to new drug classes.
Learn how HIV uses tRNA during replication
Learn how our technology can add value to your company
Download company information & technology information
Read about the NEW Trana HIV 201 Assay




  • New Trana HIV 201 Assay screens 50,000 compounds per day more >>

  • Proprietary and patented technology

  • Actively seeking licensing partners for HIV assay

  • Contact us at: info@tranadiscovery.com
    1-866-390-3452 (toll free)
    1-919-342-6192 (int'l)



Jan 2008 - Trana Discovery and Southern Research Institute Prove Assay’s Ability to Identify Compounds That Inhibit HIV Replication

Read more>

 

• HIV (cause of AIDS)
• Methicillin-resistant Staphylococcus aureus (MRSA)
• Multi-drug resistant tuberculosis
• Malaria
• Biodefense-related infectious diseases
• Other diseases of the developing world


Copyright © 2008 Trana Discovery, Inc. All rights reserved
Home | About Us | Technology | Assays | News | Contact | Privacy Policy